These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 1081403)
1. Heterogeneity in biological activity of human factor VIII antibodies. Koutts J; Meyer D; Rickard K; Stott L; Firkin BG Br J Haematol; 1975 Jan; 29(1):99-107. PubMed ID: 1081403 [TBL] [Abstract][Full Text] [Related]
2. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor. Bovill EG; Ershler WB; Golden EA; Tindle BH; Edson JR Am J Clin Pathol; 1986 Jan; 85(1):115-23. PubMed ID: 3079626 [TBL] [Abstract][Full Text] [Related]
3. Acquired von Willebrand syndrome with inhibitors both to factor VIII clotting activity and ristocetin-induced platelet aggregation. Stableforth P; Tamagnini GL; Dormandy KM Br J Haematol; 1976 Aug; 33(4):565-73. PubMed ID: 1087568 [TBL] [Abstract][Full Text] [Related]
4. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease. Barbui T; Dini E Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074 [TBL] [Abstract][Full Text] [Related]
5. Evidence that factor VIII and the ristocetin aggregating factor (VIIIRist) are separate molecular entities. Hougie C; Sargeant RB; Brown JE; Baugh RF Proc Soc Exp Biol Med; 1974 Oct; 147(1):58-61. PubMed ID: 4548194 [No Abstract] [Full Text] [Related]
6. Investigations on the relationship of factor VIII related antigen, factor VIII procoagulant activity and Von Willebrand factor activity using insolubilized rabbit antiserum. Bouma BN; de Graaf S; Hordijk-Hos JM; van Mourik JA; Sixma JJ Thromb Res; 1975 Nov; 7(5):695-707. PubMed ID: 1082181 [No Abstract] [Full Text] [Related]
7. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII. Weiss HJ; Rogers J; Brand H J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262 [TBL] [Abstract][Full Text] [Related]
8. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope. Goodall AH; Jarvis J; Chand S; Rawlings E; O'Brien DP; McGraw A; Hutton R; Tuddenham EG Br J Haematol; 1985 Apr; 59(4):565-77. PubMed ID: 2580547 [TBL] [Abstract][Full Text] [Related]
9. The nature of the interaction between ristocetin-Willebrand factor VIII coagulant activity molecule. Brockway WJ; Fass DN J Lab Clin Med; 1977 Jun; 89(6):1295-1305. PubMed ID: 16975 [No Abstract] [Full Text] [Related]
10. [Studies on the effects of five monoclonal antibodies, polyclonal rabbit antibody and homologous antibody to human F VIII/vWF on ristocetin-induced platelet agglutination and platelet retention by glass bead column]. Ogata K; Minami S; Kamiya T Rinsho Ketsueki; 1985 Jul; 26(7):1042-9. PubMed ID: 2414486 [No Abstract] [Full Text] [Related]
11. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy. Lian EC; Deykin D Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143 [TBL] [Abstract][Full Text] [Related]
12. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin. Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011 [TBL] [Abstract][Full Text] [Related]
13. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease. Gralnick HR; Coller BS; Sultan Y J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491 [TBL] [Abstract][Full Text] [Related]
14. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944 [TBL] [Abstract][Full Text] [Related]
15. A critical evaluation of the available methods for the determination of factor VIII von Willebrand. Casonato A; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633 [TBL] [Abstract][Full Text] [Related]
16. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783 [TBL] [Abstract][Full Text] [Related]
17. Factor VIII in von Willebrand' disease. Irwin JF Semin Thromb Hemost; 1975 Oct; 2(2):85-104. PubMed ID: 798271 [No Abstract] [Full Text] [Related]